Business Description
Excelsior Medical Co Ltd
ISIN : TW0004104005
Total Employee Number:
774Compare
Compare
Traded in other countries / regions
4104.Taiwan Index Membership
TSEC Weighted Index IPO Date
2007-12-31Description
Excelsior Medical Co Ltd is engaged in the sale of medical supplies and medicines, home medical devices, and medical equipment with brand names of local and foreign manufacturers. Its product offerings include Fasflo hollow fiber dialyzer, Renabio sodium chloride injection, acid concentrates, Sunder blood purification tubing set, JMS blood bags, etc. The Group's reportable segments include Excelsior, Dynamic, Arich, and Others. Maximum revenue is generated from the Excelsior segment. Geographically, it derives key revenue from Taiwan and also has a presence in Hong Kong, China, the Philippines, Malaysia, and Indonesia.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.16 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 0.79 | |||||
Interest Coverage | 21.41 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.25 | |||||
Beneish M-Score | -2.34 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7 | |||||
3-Year EBITDA Growth Rate | 8.6 | |||||
3-Year EPS without NRI Growth Rate | 7.9 | |||||
3-Year Book Growth Rate | 3.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.85 | |||||
9-Day RSI | 50.78 | |||||
14-Day RSI | 51.98 | |||||
3-1 Month Momentum % | -3.78 | |||||
6-1 Month Momentum % | -12.71 | |||||
12-1 Month Momentum % | -12.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.7 | |||||
Quick Ratio | 1.48 | |||||
Cash Ratio | 0.6 | |||||
Days Inventory | 71.67 | |||||
Days Sales Outstanding | 72.34 | |||||
Days Payable | 56.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 6.07 | |||||
Dividend Payout Ratio | 0.84 | |||||
3-Year Dividend Growth Rate | 7.9 | |||||
Forward Dividend Yield % | 6.07 | |||||
5-Year Yield-on-Cost % | 8.16 | |||||
Shareholder Yield % | -3.6 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 21.35 | |||||
Operating Margin % | 8.2 | |||||
Net Margin % | 9.08 | |||||
EBITDA Margin % | 16.96 | |||||
FCF Margin % | 2.51 | |||||
OCF Margin % | 3.46 | |||||
ROE % | 9.12 | |||||
ROA % | 4.32 | |||||
ROIC % | 5.54 | |||||
3-Year ROIIC % | 3.27 | |||||
ROC (Joel Greenblatt) % | 116.07 | |||||
ROCE % | 9.77 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.35 | |||||
Forward PE Ratio | 17.13 | |||||
PE Ratio without NRI | 16.69 | |||||
Shiller PE Ratio | 17.19 | |||||
Price-to-Owner-Earnings | 31.41 | |||||
PEG Ratio | 1.81 | |||||
PS Ratio | 1.4 | |||||
PB Ratio | 1.39 | |||||
Price-to-Tangible-Book | 1.39 | |||||
Price-to-Free-Cash-Flow | 57.62 | |||||
Price-to-Operating-Cash-Flow | 41.44 | |||||
EV-to-EBIT | 10.85 | |||||
EV-to-EBITDA | 8.63 | |||||
EV-to-Revenue | 1.47 | |||||
EV-to-FCF | 58.4 | |||||
Price-to-GF-Value | 0.81 | |||||
Price-to-Projected-FCF | 0.96 | |||||
Price-to-Median-PS-Value | 1.16 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.71 | |||||
Price-to-Graham-Number | 1.02 | |||||
| Price-to-Net-Current-Asset-Value | 13.56 | |||||
Earnings Yield (Greenblatt) % | 9.23 | |||||
FCF Yield % | 1.69 | |||||
Forward Rate of Return (Yacktman) % | 13.31 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Excelsior Medical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 8,982.869 | ||
| EPS (TTM) (NT$) | 4.614 | ||
| Beta | 0.2226 | ||
| 3-Year Sharpe Ratio | -0.98 | ||
| 3-Year Sortino Ratio | -1.18 | ||
| Volatility % | 8.3 | ||
| 14-Day RSI | 51.98 | ||
| 14-Day ATR (NT$) | 0.84473 | ||
| 20-Day SMA (NT$) | 70.735 | ||
| 12-1 Month Momentum % | -12.58 | ||
| 52-Week Range (NT$) | 67.3 - 85.366049 | ||
| Shares Outstanding (Mil) | 188.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Excelsior Medical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Excelsior Medical Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 4.300000 Cash Dividend | 2026-04-23 | 78.60 (+0.00%) | ||
| 1.05:1 Stock Split | 2025-09-09 | 82.80 (-0.11%) | ||
| TWD 3.559260 Cash Dividend | 2025-04-24 | 82.61 (-0.68%) | ||
| 1.05:1 Stock Split | 2024-08-26 | 81.71 (+0.11%) | ||
| 1.05:1 Stock Split | 2023-08-28 | 77.65 (+1.44%) | ||
| 1.05:1 Stock Split | 2022-08-30 | 55.42 (+2.24%) | ||
| 1.1:1 Stock Split | 2012-09-19 | 48.21 (-0.30%) | ||
| 0.8:1 Stock Split | 2007-12-11 | -- | ||
| 1.06979:1 Stock Split | 2006-08-02 | -- | ||
| 1.03:1 Stock Split | 2005-08-25 | -- |
Show
Entries
Excelsior Medical Co Ltd Frequently Asked Questions
What is Excelsior Medical Co Ltd(TPE:4104)'s stock price today?
The current price of TPE:4104 is NT$70.80. The 52 week high of TPE:4104 is NT$85.37 and 52 week low is NT$67.30.
When is next earnings date of Excelsior Medical Co Ltd(TPE:4104)?
The next earnings date of Excelsior Medical Co Ltd(TPE:4104) is .
Does Excelsior Medical Co Ltd(TPE:4104) pay dividends? If so, how much?
The Dividend Yield %  of Excelsior Medical Co Ltd(TPE:4104) is 6.07% (As of Today), Highest Dividend Payout Ratio of Excelsior Medical Co Ltd(TPE:4104) was 0.98. The lowest was 0.74. And the median was 0.83. The  Forward Dividend Yield % of Excelsior Medical Co Ltd(TPE:4104) is 6.07%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Excelsior Medical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers